Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Dec 10, 2014; 5(5): 845-857
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.845
Table 1 Search strategy
StepStringResults
1Exp Bone Neoplasms/sc OR Bone Neoplasms/rt OR [(boneCarcinoma/sc OR exp Neoplasm Metastasis/rt) AND exp “Bone and Bones”/] OR [(osseous OR skeletal) ADJ3 metastasis$] OR (bone ADJ3 metastasis$)26956
2Exp *Lung Neoplasms/OR exp Lung Neoplasms/pa OR lung cancer.mp188189
3Exp Radiotherapy/OR exp Dose Fractionation/OR exp Radiotherapy Dosage/133052
4Exp Palliative Care/OR exp Pain/RT OR Pain Management/mt OR (palliative OR palliation).mp OR painful adj3 metastasis$ OR (palliative$ ADJ3 radiotherapy).mp94404
51 AND 2 AND 3 AND 488 Limit 10 yr: 28
61 AND 3 AND 4 Exclusion criteria: non-lung primary site cancers608 Limit 10 yr: 256
7(1 AND 4 AND radiotherapy.mp AND combined modality therapy/OR analgesics/OR treatment outcome/OR quality of life/OR exp Antineoplastic Combined Chemotherapy Protocols) NOT 6129 Limit 10 yr: 50
8Total156